Recombinant streptokinase: evidences from clinical use.

In the study of Hermentin et al. ,1 a significant discrepancy between claimed and measured streptokinase (SK) activity of various tested products was found in addition to other physicochemical differences. However, it is difficult to interpret the results as they analysed only one sample of most products, and in some cases even from only one batch. The authors also raise the matter of the relationship between their data and clinical performance, but this kind of statement should be backed up by …